We are live on ! Find out more
AUXL

AUXILIUM PHARAMCEUTICALS INC
AUXL

Delisted

AUXL was delisted on the 29th of January, 2015.

Back to rankings

163 hedge funds and large institutions have $1.57B invested in AUXILIUM PHARAMCEUTICALS INC in 2014 Q1 according to their latest regulatory filings, with 44 funds opening new positions, 51 increasing their positions, 52 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

855% more call options, than puts

Call options by funds: $268M | Put options by funds: $28M

69% more first-time investments, than exits

New positions opened: 44 | Existing positions closed: 26

41% more capital invested

Capital invested by funds: $1.11B → $1.57B (+$458M)

17% more funds holding in top 10

Funds holding in top 10: 6 → 7 (+1)

11% more funds holding

Funds holding: 147 → 163 (+16)

2% less repeat investments, than reductions

Existing positions increased: 51 | Existing positions reduced: 52

Holders
163
Holders Change
+16
Holders Change %
+10.88%
% of All Funds
4.71%
Holding in Top 10
7
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+16.67%
% of All Funds
0.2%
New
44
Increased
51
Reduced
52
Closed
26
Calls
$268M
Puts
$28M
Net Calls
+$239M
Net Calls Change
+$57.8M

Top Buyers

Rank Fund Capital Flow
1
PC
Paulson & Co
New York
+$106M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$71M
3
TCM
TimesSquare Capital Management
New York
+$32.7M
4
Franklin Resources
Franklin Resources
California
+$28.6M
5
GIM
Granahan Investment Management
Massachusetts
+$25.8M

Top Sellers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
-$41.1M
2
PHS
PFM Health Sciences
California
-$40.3M
3
PI
Putnam Investments
Massachusetts
-$40.1M
4
AC
Amici Capital
New York
-$17.1M
5
LOAMU
Lombard Odier Asset Management (USA)
New York
-$16.6M
Name Holding Trade Value Shares
Change 		Change in
Stake
HT
176
HAP Trading
New York
– -$1.14M -54,866 Closed
SCM
177
Sigma Capital Management
Connecticut
– -$1.04M -50,000 Closed
GC
178
Globeflex Capital
California
– -$1.03M -49,900 Closed
BNP Paribas Financial Markets
179
BNP Paribas Financial Markets
France
– -$945K -45,541 Closed
AA
180
AlphaMark Advisors
Kentucky
– -$832K -40,114 Closed
SIM
181
SSI Investment Management
California
– -$690K -33,289 Closed
AA
182
ALPS Advisors
Colorado
– -$686K -26,801 Closed
IAM
183
Integre Asset Management
New York
– -$503K -24,255 Closed
NCCM
184
Nine Chapters Capital Management
New Jersey
– -$369K -17,800 Closed
Los Angeles Capital Management
185
Los Angeles Capital Management
California
– -$216K -10,440 Closed
VIA
186
Vantage Investment Advisors
Pennsylvania
– -$50K -2,390 Closed
TRCT
187
Tower Research Capital (TRC)
New York
– -$6K -300 Closed
NES
188
New England Securities
New York
– -$6K -282 Closed
ASN
189
Advisory Services Network
Georgia
– -$5K -245 Closed
4 5 6 7
8

AUXL Hedge Fund Activity: Q1 2014 in Review

163 of the 3,464 institutional investors tracked by Wall St. Rank reported a position in AUXILIUM PHARAMCEUTICALS INC (AUXL) for Q1 2014, worth a combined $1.57B — up 41% from $1.11B a quarter earlier.

Buyers outnumbered sellers: 44 funds opened new AUXL positions and 26 closed out — a net gain of 18 holders — while 51 added to existing stakes and 52 trimmed.

The largest buyer was Paulson & Co, opening a new position worth an estimated $106M. The largest seller was Deerfield Management, cutting an estimated $41.1M.

  • 163 institutional investors held AUXILIUM PHARAMCEUTICALS INC (AUXL) as of Q1 2014, up from 147 in Q4 2013.
  • Funds reported $1.57B of AUXILIUM PHARAMCEUTICALS INC stock for Q1 2014, up 41% quarter-over-quarter.
  • 44 funds opened new AUXILIUM PHARAMCEUTICALS INC positions in Q1 2014 and 26 closed out, a net change of +18 holders.
  • The largest AUXILIUM PHARAMCEUTICALS INC buyer in Q1 2014 was Paulson & Co, an estimated $106M added.
  • The largest AUXILIUM PHARAMCEUTICALS INC seller in Q1 2014 was Deerfield Management, an estimated $41.1M sold.

Based on aggregated 13F filings for Q1 2014.